Described herein are pharmaceutical packaging devices which avoid oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medicines, these kinds of programs such as a syringe having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with extremely low permeability to oxygen and comp